2005
DOI: 10.1128/aac.49.2.560-564.2005
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of the Antiviral Agent β- l -3′-Fluoro-2′,3′-Didehydro-2′,3′-Dideoxycytidine in Rhesus Monkeys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 28 publications
0
5
0
Order By: Relevance
“…(Table 2), which is higher than other nucleoside RT inhibitors (2,3). Approximately 72% of the absorbed dose was recovered unchanged in the urine after oral administration in monkeys (CL R /CL T ).…”
Section: Discussionmentioning
confidence: 94%
“…(Table 2), which is higher than other nucleoside RT inhibitors (2,3). Approximately 72% of the absorbed dose was recovered unchanged in the urine after oral administration in monkeys (CL R /CL T ).…”
Section: Discussionmentioning
confidence: 94%
“…Nevertheless, a chemical and enzymatic stability study demonstrated that the 3′-F substitution stabilized the glycosyl bond. A pharmacokinetic study in three rhesus monkeys following single-dose oral administration of 3′F-β- l- d4C showed a mean maximum plasma concentration ( C max ) = 4.4 μg/mL and time of maximum concentration ( T max ) = 1.67 h . The concentration of 3′F-β- l- d4C in the plasma of rhesus monkeys remained higher than the EC 90 value against wild-type HIV-1 12 h after the oral doses.…”
Section: Biologically Active Compounds Containing L-pentosesmentioning
confidence: 96%
“…The pharmacokinetic properties in rhesus monkeys of L-3'-F-d4C (82), a potent inhibitor of HIV and HBV, have been described [315]. While the compound was orally bioavailable, variability in exposure was observed that was not abrogated by coadministration with sodium bicarbonate solution as a basic buffer to reduce the potential for hydrolytic cleavage of the sugar ring [315].…”
Section: Nrtis In Developmentmentioning
confidence: 96%
“…The pharmacokinetic properties in rhesus monkeys of L-3'-F-d4C (82), a potent inhibitor of HIV and HBV, have been described [315]. While the compound was orally bioavailable, variability in exposure was observed that was not abrogated by coadministration with sodium bicarbonate solution as a basic buffer to reduce the potential for hydrolytic cleavage of the sugar ring [315]. Structure-activity relationships for L-3'Fd4C (82) have revealed that the enantiomer with a natural sugar configuration, D-3'F-d4C (83), inhibited HIV-1 replication in cell culture with an EC 50 = 2.3 µM, over 25-fold weaker than for 82 [316].…”
Section: Nrtis In Developmentmentioning
confidence: 99%